戈壁创投唐启波：香港科创生态持续完善，耐心资本助力长期创新

Core Viewpoint - The article discusses the revitalization of Hong Kong's financial market and its positive impact on the local tech innovation ecosystem, highlighting the establishment of the "Patient Capital Strategy Fund" to support long-term investments in Hong Kong's tech sector [1][2]. Group 1: Investment Landscape - Gobi Partners has invested in over 70 local Hong Kong companies since entering the market in 2016, including 8 unicorns, demonstrating a strong commitment to the region's tech ecosystem [2][4]. - The Hong Kong government has launched over HKD 10 billion in funding initiatives to support tech innovation, enhancing the conversion of university research into marketable projects [4][12]. Group 2: Patient Capital Strategy Fund - The "Patient Capital Strategy Fund" aims to attract long-term capital, particularly from sovereign funds, to support deep tech projects in areas like AI, advanced manufacturing, biotech, and green technology [5][6]. - The fund seeks to promote collaboration between academia and industry, enhancing the commercialization of research outcomes from Hong Kong's top universities [5][12]. Group 3: Advantages of Hong Kong - Hong Kong's international financial center status provides a favorable legal and regulatory environment, making it easier for tech companies to gain international investor trust and conduct cross-border business [10][11]. - The region's geographical position allows tech companies to leverage both mainland China's resources and global market access, enhancing their operational capabilities [11][12]. - The capital market in Hong Kong is more mature and internationalized compared to mainland cities, offering diverse financing options for tech companies at various stages of growth [11][13]. Group 4: Challenges and Improvements - While Hong Kong's tech financing ecosystem has some shortcomings, particularly in early-stage investments, recent government initiatives and university-led funds are improving the situation [12][13]. - The IPO market in Hong Kong has become increasingly favorable for tech companies, with reforms allowing for more flexible listing options, which has led to a significant increase in tech and biotech IPOs [13].